Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

The Global Vitamin D Supplements Market (2018-2023): Exponential Growth of 12.4% CAGR is Expected - ResearchAndMarkets.com

Research and Markets
Posted on: 22 Oct 18

The "Global Vitamin D Supplements Market - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The global vitamin D supplements market is expected to register exponential growth, with a double-digit CAGR of 12.4% during the forecast period (2018-2023), due to the hectic lifestyle, increasing health consciousness, evolving dietary patterns, and the increasing demand for vitamin supplements, in the backdrop of emerging cases of micronutrient deficiencies.

Dietary supplements are continuously evolving, in order to cater to the niche population segments (pregnant and breast-feeding women, geriatric, and pediatric nutrition) and due to intensive fortification initiatives undertaken by governments, the world over. The increasing awareness related to vitamin supplements has led to favorable sentiments toward the vitamin supplements market.

Under supplements and fortified foods, vitamin D is available in two forms - D2 (ergocalciferol) and D3 (cholecalciferol) that are molecularly different. The vitamin D2 (ergocalciferol) segment is expected to grow at a higher rate comparatively, as it is available from non-animal sources (fungi and plants) as opposed to vitamin D3 (cholecalciferol), which is animal-derived. However, most studies have found that vitamin D2 is much less potent than D3 in raising the level of vitamin D in the blood stream. Asia-Pacific is projected to be the fastest-growing market for vitamin D supplements, due to the increasing consumer awareness regarding vitamin D deficiency, and growing incidences of diseases, such as osteoporosis, osteomalacia, and rickets, in countries, such as India and China. In India, as food fortification is deficient, supplementing with pharmaceutical preparations is the only means of treatment of vitamin D deficiency. However, due to lack of awareness regarding the daily recommended dosage, there is a need for marketing and rational prescribing of the appropriate vitamin D supplement in the Asia-Pacific region.

Major Market Developments

  • Researchers from Medical College of Georgia at University of Augusta have quoted, based on randomized trials that large dosage of vitamin D rapidly reduces arterial stiffness.
  • The US-based Pure Mountain Botanicals launched a new product - 5000 IU Vitamin D3 Drops that can be conveniently consumed with juice, water, or any beverage.

Key Topics Covered

1. Introduction

2. Vitamin D Supplements Research Approach and Methodology

3. Vitamin D Supplements Market Overview

4. Vitamin D Supplements Market Segmentation

5. Vitamin D Supplements Competitive Landscape

6. Company Profiles

  • Abott Nutrition
  • Amway
  • Bayer AG
  • Cadila Pharmaceutical
  • Glanbia PLC
  • GlaxoSmithKline
  • GNC
  • Natures Bounty Inc.
  • Pfizer Inc.
  • Reckitt Benckiser
  • Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/586zlh/the_global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181022005449/en/

Business Wire
www.businesswire.com

Last updated on: 22/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.